ArticleFrontiers in public health2023
The re-emergence and transmission of Monkeypox virus in Nigeria: the role of one health.
Article in Frontiers in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 36 citations in OpenAlex.
- Strengthening Global Health Security in West Africa: Insights from Joint External Evaluations and After-Action Reviews.Dialogues in health · 2026Review
- Mpox and the one health approach.Dialogues in health · 2026Review
- Mpox outbreak preparedness and response capacity in Nigeria's Federal Capital Territory: a mixed-methods study.BMC public health · 2026Article
- SWOT analysis of Mpox surveillance in high-burden districts in Uganda, February-March 2025.One health outlook · 2026Article
- Monkey pox (Mpox): pathogenesis, genetic shifts, vaccination strategies and clinical insights.Archives of microbiology · 2026Review
- Associations between the 2022 global mpox outbreak and multifaceted factors: A multi-geographical retrospective study.One health (Amsterdam, Netherlands) · 2025Article
- Diagnostic Advances and Public Health Challenges for Monkeypox Virus: Clade-Specific Insight and the Urgent Need for Rapid Testing in Africa.Diagnostics (Basel, Switzerland) · 2025Review
- From neglected to notoriety: a review of Mpox clinical features, virology, epidemiology, treatment and prevention strategies.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025Review
- Serological differentiation between naturally acquired mpox and MVA-BN-vaccine induced antibody responses using ratios of MPXV and VACV antigen pairs in the MSD immunoassay.Microbiology spectrum · 2025Article
- Mpox unveiled: Global epidemiology, treatment advances, and prevention strategies.One health (Amsterdam, Netherlands) · 2025Review
- Review
- Understanding the resurgence of mpox: key drivers and lessons from recent outbreaks in Africa.Tropical medicine and health · 2025Review
- Article
- The resurgence of monkeypox virus: a critical global health challenge and the need for vigilant intervention.Frontiers in public health · 2025Review
- Risk perception and factors associated with the acceptance of smallpox vaccine against monkeypox among healthcare and healthcare support workers in Northeastern Nigeria.The Pan African medical journal · 2025Article
- Mpox: An emerging or re-emerging infection with a potential colossal burden on healthcare globally.African journal of laboratory medicine · 2025Review
- Non-exanthematous mpox infections in Nigeria: a possible explanation of the sporadic outbreaks in city centers?The Pan African medical journal · 2025Article
- Mpox in East Africa: Learning from COVID-19 and Ebola to Strengthen Public Health Responses.Viruses · 2024Article
- A critical review of mpox outbreaks, risk factors, and prevention efforts in Africa: lessons learned and evolving practices.IJID regions · 2024Review
- Clade Ib: a new emerging threat in the Mpox outbreak.Frontiers in pharmacology · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Monkeypox virus, commonly abbreviated as mpox, is a viral zoonosis that is experiencing a resurgence in prevalence. It is endemic to regions of West and Central Africa that are characterized by dense forested areas. Various measures pertaining to animals, humans, and the environment have been recognized as potential factors and catalysts for the spread of the disease throughout the impacted regions of Africa. This study examines the various factors contributing to the transmission of the virus in Nigeria, with a particular focus on the animal-human and inter-human modes of transmission in rural communities and healthcare facilities. The One Health approach was emphasized as crucial in the prevention and management of this issue. Literature suggests that preventing repeated zoonotic introductions could potentially halt the transmission of the mpox virus from animal to human hosts, leading to a potential decrease in human infections.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.